Navigation Links
New partnership offers outsourced R&D in membrane biology
Date:9/24/2007

One of the UK's most successful academic entrepreneurs has teamed up with the University of Leeds to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies.

Dr Tony Marchington, who turned his spin-out company Oxford Molecular into a business worth 450m, will work alongside the Universitys new Centre for Integrative Membrane Biology (CIMB) to broker research contracts with industry, based on Leeds world-class expertise in membrane biology.

Membrane biology research is central to the improved treatment of human disease with pharmaceutical drugs; currently around 75 per cent of current drugs have their effects via membrane proteins(1).

The partnership between CIMB, based at the Universitys Faculty of Biological Sciences, and M2 Ventures - Dr Marchingtons new company set up with finance expert Martin Manning - will offer a co-ordinated expert research resource to industry addressing membrane function at all levels: the biology of single cells through to whole organisms; analysis of protein structure and function; membranes on devices and high throughput interrogation platforms, such as for sensor technologies.

Says Dr Marchington: As the pharma and healthcare industries continue the trend to outsource their fundamental research and early stage development, the natural recipients of this work are universities, such as Leeds, that have both research excellence in these areas and can package and offer that expertise in ways that meet industry requirements.

Its self-evident that Leeds has exceptional breadth of expertise including world-class research capability in membrane biology; and as the market for targeted drugs accelerates, we believe that there will be great demand for their services. With our combined knowledge, experience and contacts, we are in a formidable position to capitalise on the strengths of this partnership.

The partnership was brokered by Leeds Professors Deborah Withington and John Colyer both of whom have extensive commercial experience. Professor Withington said: This partnership has all the hallmarks of something very special and were excited by its potential.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-011-325-89880
University of Leeds
Source:Eurekalert

Related biology news :

1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New partnership to clear landmines for African Elephants
3. Gut microbes partnership helps body extract energy from food, store it as fat
4. Protein offers way to stop microscopic parasites in their tracks
5. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
6. Gene silencing technique offers new strategy for treating, curing disease
7. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Transgenic goats milk offers hope for tackling childrens intestinal disease
10. Engineered skin offers clues to melanoma development
11. GM crop that holds on to its seeds offers higher yields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:8/23/2017)... , ... August 23, 2017 , ... ... systems, announced orders for advanced VPG+ 800 Volume Pattern Generators from two major ... fulfill tomorrow’s demand for production of advanced photomasks as well as a solution ...
(Date:8/22/2017)... ... August 22, 2017 , ... One of ... the practice of opioid-dose sparing. Opioid-dose sparing refers to the reduction of opioid ... with non-steroidal anti-inflammatory drugs (NSAIDs). , The potential for new therapies to replace ...
(Date:8/21/2017)... ... August 21, 2017 , ... Finalists have recently been ... centers that have implemented innovative products, services, and technology over the past year. ... financial impact/value, and market need. The applicants with the top three scores in ...
(Date:8/21/2017)... ... August 21, 2017 , ... Today Aether announced that Aether ... by a Bill and Melinda Gates Foundation grant, to pursue a ... Gates Foundation, also known as the Gates Foundation, is said to be the largest ...
Breaking Biology Technology: